Results
1 -
10 of
102Pharmacological evidence for a selective antidopaminergic action of gamma-hydroxybutyric acid, Journal of Neural Transmission The regulation of striatal tyrosine hydroxylase, Naunyn-Schmiedeberg's Archives of Pharmacology Decreased 3H-l-quinuclidinyl benzilate binding and muscarine receptor subsensitivity after chronic gamma-butyrolactone treatment, Naunyn-Schmiedeberg's Archives of Pharmacology Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra, Naunyn-Schmiedeberg's Archives of Pharmacology Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow, Naunyn-Schmiedeberg's Archives of Pharmacology Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gammahydroxybutyric acid, Naunyn-Schmiedeberg's Archives of Pharmacology Inhibition of the turnover of the brain dopamine after treatment with the gammaaminobutyrate: 2-oxyglutarate transaminase inhibitor aminooxyacetic acid, Naunyn-Schmiedeberg's Archives of Pharmacology Increased food intake following the manipulation of intracerebral dopamine levels with gamma-hydroxybutyrate, Psychopharmacology Drugs of Abuse, Handbook of Drug Interactions